Univentricular Heart
20
7
7
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 20 trials
100.0%
+13.5% vs benchmark
5%
1 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (20)
Fontan Outcomes in Oligemia vs Plethora in Univentricular CHD
Occlutech AFR Fontan Study
Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease
Registry to Assess the Safety and Feasibility of the Subpulmonary Support with the Novel Venous Cannula in Patients with Failing/Absence of the Right Heart
Cardiac Magnetic Resonance Stress-perfusion Study in Patinets with Fontan Circulation
Effect of Muscle Strengthening Training in Adults with Fontan Circulation
Interstage Monitoring Using an Implantable Loop Recorder: A Pilot Study
Lymphatic Function in Patients With Fontan Circulation: Effect of Physical Training
Lymphatic Morphology of Fontan Patients
Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Disease
Respiratory Drive in Patients With Univentricular Congenital Heart Disease
Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease
Impact of Exercise Training on Single Ventricle Function in Paediatric Fontan Patients
Cardiovascular, Pulmonary and Skeletal Muscle Evaluation Postoperative in Fontan Patients: Effects of Exercise Training
Prospective Evaluation of Univentricular Hearts
Fontan-Sprechstunde
Factors Associated With Normal Exercise Capacity in Patients With Single Ventricle
Aesculus Hippocastanum L. on Fontan Circulation
Lymphatic Function in Patients With a Fontan Circulation From Brazil
Lymphatic Function in Patients With a Fontan-Kreutzer Circulation